Report for Anand R

General

Full name : Anand Rene

First name : Rene

Mail : LSU Medical Center - Neuroscience Center,2020 Gravier Street - Suite D,New Orleans, LA 70112

Zip Code :

City :

Country : USA

Email : ranand@lsumc.edu

Phone : I 504 599 0847

Fax : I 504 599 0891

Website :

Directory :

References (24)

Title : A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells - Moore_2022_ACS.Chem.Biol_17_2595
Author(s) : Moore KP , Schwaid AG , Tudor M , Park S , Beshore DC , Converso A , Shipe WD , Anand R , Lan P , Moningka R , Rothman DM , Sun W , Chi A , Cornella-Taracido I , Adam GC , Bahnck-Teets C , Carroll SS , Fay JF , Goh SL , Lusen J , Quan S , Rodriguez S , Xu M , Andrews CL , Song C , Filzen T , Li J , Hollenstein K , Klein DJ , Lammens A , Lim UM , Fang Z , McHale C , Li Y , Lu M , Diamond TL , Howell BJ , Zuck P , Balibar CJ
Ref : ACS Chemical Biology , 17 :2595 , 2022
Abstract : Moore_2022_ACS.Chem.Biol_17_2595
ESTHER : Moore_2022_ACS.Chem.Biol_17_2595
PubMedSearch : Moore_2022_ACS.Chem.Biol_17_2595
PubMedID: 36044633
Gene_locus related to this paper: human-DPP8 , human-DPP9

Title : Therapeutics of Alzheimer's disease: Past, present and future - Anand_2014_Neuropharmacol_76 Pt A_27
Author(s) : Anand R , Gill KD , Mahdi AA
Ref : Neuropharmacology , 76 Pt A :27 , 2014
Abstract : Anand_2014_Neuropharmacol_76 Pt A_27
ESTHER : Anand_2014_Neuropharmacol_76 Pt A_27
PubMedSearch : Anand_2014_Neuropharmacol_76 Pt A_27
PubMedID: 23891641

Title : Nonhuman genetics. Genomic basis for the convergent evolution of electric organs - Gallant_2014_Science_344_1522
Author(s) : Gallant JR , Traeger LL , Volkening JD , Moffett H , Chen PH , Novina CD , Phillips GN, Jr. , Anand R , Wells GB , Pinch M , Guth R , Unguez GA , Albert JS , Zakon HH , Samanta MP , Sussman MR
Ref : Science , 344 :1522 , 2014
Abstract : Gallant_2014_Science_344_1522
ESTHER : Gallant_2014_Science_344_1522
PubMedSearch : Gallant_2014_Science_344_1522
PubMedID: 24970089
Gene_locus related to this paper: eleel-BCHE , eleel-a0a4w4gcb7 , eleel-a0a4w4dt57

Title : Presynaptic targeting of alpha4beta 2 nicotinic acetylcholine receptors is regulated by neurexin-1beta - Cheng_2009_J.Biol.Chem_284_23251
Author(s) : Cheng SB , Amici SA , Ren XQ , McKay SB , Treuil MW , Lindstrom JM , Rao J , Anand R
Ref : Journal of Biological Chemistry , 284 :23251 , 2009
Abstract : Cheng_2009_J.Biol.Chem_284_23251
ESTHER : Cheng_2009_J.Biol.Chem_284_23251
PubMedSearch : Cheng_2009_J.Biol.Chem_284_23251
PubMedID: 19567877

Title : Mutations of cytosolic loop residues impair assembly and maturation of alpha7 nicotinic acetylcholine receptors - Mukherjee_2009_J.Neurochem_110_1885
Author(s) : Mukherjee J , Kuryatov A , Moss SJ , Lindstrom JM , Anand R
Ref : Journal of Neurochemistry , 110 :1885 , 2009
Abstract : Mukherjee_2009_J.Neurochem_110_1885
ESTHER : Mukherjee_2009_J.Neurochem_110_1885
PubMedSearch : Mukherjee_2009_J.Neurochem_110_1885
PubMedID: 19627445

Title : Structural determinants of alpha4beta2 nicotinic acetylcholine receptor trafficking - Ren_2005_J.Neurosci_25_6676
Author(s) : Ren XQ , Cheng SB , Treuil MW , Mukherjee J , Rao J , Braunewell KH , Lindstrom JM , Anand R
Ref : Journal of Neuroscience , 25 :6676 , 2005
Abstract : Ren_2005_J.Neurosci_25_6676
ESTHER : Ren_2005_J.Neurosci_25_6676
PubMedSearch : Ren_2005_J.Neurosci_25_6676
PubMedID: 16014729

Title : Impact of study design and patient population on outcomes from cholinesterase inhibitor trials - Anand_2003_Am.J.Geriatr.Psychiatry_11_160
Author(s) : Anand R , Hartman R , Sohn H , Danyluk J , Graham SM
Ref : American Journal of Geriatry & Psychiatry , 11 :160 , 2003
Abstract : Anand_2003_Am.J.Geriatr.Psychiatry_11_160
ESTHER : Anand_2003_Am.J.Geriatr.Psychiatry_11_160
PubMedSearch : Anand_2003_Am.J.Geriatr.Psychiatry_11_160
PubMedID: 12611745

Title : The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4beta 2 nicotinic acetylcholine receptor - Lin_2002_J.Biol.Chem_277_41872
Author(s) : Lin L , Jeanclos EM , Treuil M , Braunewell KH , Gundelfinger ED , Anand R
Ref : Journal of Biological Chemistry , 277 :41872 , 2002
Abstract : Lin_2002_J.Biol.Chem_277_41872
ESTHER : Lin_2002_J.Biol.Chem_277_41872
PubMedSearch : Lin_2002_J.Biol.Chem_277_41872
PubMedID: 12202488

Title : Electrocardiographic effects of rivastigmine - Morganroth_2002_J.Clin.Pharmacol_42_558
Author(s) : Morganroth J , Graham S , Hartman R , Anand R
Ref : Journal of Clinical Pharmacology , 42 :558 , 2002
Abstract : Morganroth_2002_J.Clin.Pharmacol_42_558
ESTHER : Morganroth_2002_J.Clin.Pharmacol_42_558
PubMedSearch : Morganroth_2002_J.Clin.Pharmacol_42_558
PubMedID: 12017350

Title : Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease - Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
Author(s) : Potki SG , Anand R , Hartman R , Veach J , Grossberg G
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 26 :713 , 2002
Abstract : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
ESTHER : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
PubMedSearch : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713
PubMedID: 12188104

Title : Barriers to drug discovery and development for Alzheimer disease - Fillit_2002_Alzheimer.Dis.Assoc.Disord_16 Suppl 1_S1
Author(s) : Fillit HM , O'Connell AW , Brown WM , Altstiel LD , Anand R , Collins K , Ferris SH , Khachaturian ZS , Kinoshita J , Van Eldik L , Dewey CF
Ref : Alzheimer Disease & Associated Disorders , 16 Suppl 1 :S1 , 2002
Abstract : Fillit_2002_Alzheimer.Dis.Assoc.Disord_16 Suppl 1_S1
ESTHER : Fillit_2002_Alzheimer.Dis.Assoc.Disord_16 Suppl 1_S1
PubMedSearch : Fillit_2002_Alzheimer.Dis.Assoc.Disord_16 Suppl 1_S1
PubMedID: 12070355

Title : A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances - Weiser_2002_Int.J.Geriatr.Psychiatry_17_343
Author(s) : Weiser M , Rotmensch HH , Korczyn AD , Hartman R , Cicin-Sain A , Anand R
Ref : Int J Geriatr Psychiatry , 17 :343 , 2002
Abstract : Weiser_2002_Int.J.Geriatr.Psychiatry_17_343
ESTHER : Weiser_2002_Int.J.Geriatr.Psychiatry_17_343
PubMedSearch : Weiser_2002_Int.J.Geriatr.Psychiatry_17_343
PubMedID: 11994888

Title : Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression - Farlow_2001_Arch.Neurol_58_417
Author(s) : Farlow MR , Hake A , Messina J , Hartman R , Veach J , Anand R
Ref : Archives of Neurology , 58 :417 , 2001
Abstract : Farlow_2001_Arch.Neurol_58_417
ESTHER : Farlow_2001_Arch.Neurol_58_417
PubMedSearch : Farlow_2001_Arch.Neurol_58_417
PubMedID: 11255445

Title : Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease - Potkin_2001_Int.J.Neuropsychopharmacol_4_223
Author(s) : Potkin SG , Anand R , Fleming K , Alva G , Keator D , Carreon D , Messina J , Wu JC , Hartman R , Fallon JH
Ref : Int J Neuropsychopharmacol , 4 :223 , 2001
Abstract : Potkin_2001_Int.J.Neuropsychopharmacol_4_223
ESTHER : Potkin_2001_Int.J.Neuropsychopharmacol_4_223
PubMedSearch : Potkin_2001_Int.J.Neuropsychopharmacol_4_223
PubMedID: 11602028

Title : An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors - Kumar_2000_Eur.J.Neurol_7_159
Author(s) : Kumar V , Anand R , Messina J , Hartman R , Veach J
Ref : Eur Journal of Neurology , 7 :159 , 2000
Abstract : Kumar_2000_Eur.J.Neurol_7_159
ESTHER : Kumar_2000_Eur.J.Neurol_7_159
PubMedSearch : Kumar_2000_Eur.J.Neurol_7_159
PubMedID: 10809936

Title : A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease - Farlow_2000_Eur.Neurol_44_236
Author(s) : Farlow M , Anand R , Messina J, Jr. , Hartman R , Veach J
Ref : Eur Neurol , 44 :236 , 2000
Abstract : Farlow_2000_Eur.Neurol_44_236
ESTHER : Farlow_2000_Eur.Neurol_44_236
PubMedSearch : Farlow_2000_Eur.Neurol_44_236
PubMedID: 11096224

Title : Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study - McKeith_2000_Lancet_356_2031
Author(s) : McKeith I , Del Ser T , Spano P , Emre M , Wesnes K , Anand R , Cicin-Sain A , Ferrara R , Spiegel R
Ref : Lancet , 356 :2031 , 2000
Abstract : McKeith_2000_Lancet_356_2031
ESTHER : McKeith_2000_Lancet_356_2031
PubMedSearch : McKeith_2000_Lancet_356_2031
PubMedID: 11145488

Title : Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications - Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
Author(s) : Grossberg GT , Stahelin HB , Messina JC , Anand R , Veach J
Ref : Int J Geriatr Psychiatry , 15 :242 , 2000
Abstract : Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
ESTHER : Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
PubMedSearch : Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242
PubMedID: 10713582

Title : Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial - Rosler_1999_BMJ_318_633
Author(s) : Rosler M , Anand R , Cicin-Sain A , Gauthier S , Agid Y , Dal-Bianco P , Stahelin HB , Hartman R , Gharabawi M
Ref : BMJ , 318 :633 , 1999
Abstract : Rosler_1999_BMJ_318_633
ESTHER : Rosler_1999_BMJ_318_633
PubMedSearch : Rosler_1999_BMJ_318_633
PubMedID: 10066203

Title : A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon) - Forette_1999_Eur.J.Neurol_6_423
Author(s) : Forette F , Anand R , Gharabawi G
Ref : Eur Journal of Neurology , 6 :423 , 1999
Abstract : Forette_1999_Eur.J.Neurol_6_423
ESTHER : Forette_1999_Eur.J.Neurol_6_423
PubMedSearch : Forette_1999_Eur.J.Neurol_6_423
PubMedID: 10362894

Title : Determinants of channel gating located in the N-terminal extracellular domain of nicotinicalpha7 receptor -
Author(s) : Anand R , Gerzanich V , Nelson ME , Wells GB , Lindstrom JM
Ref : Journal de Physiologie (Paris) , 92 :403 , 1998
PubMedID:

Title : Safety\/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease - Sramek_1996_Life.Sci_58_1201
Author(s) : Sramek JJ , Anand R , Wardle TS , Irwin P , Hartman RD , Cutler NR
Ref : Life Sciences , 58 :1201 , 1996
Abstract : Sramek_1996_Life.Sci_58_1201
ESTHER : Sramek_1996_Life.Sci_58_1201
PubMedSearch : Sramek_1996_Life.Sci_58_1201
PubMedID: 8614273

Title : Structure and function of neuronal nicotinic acetylcholine receptors -
Author(s) : Lindstrom JM , Anand R , Gerzanich V , Peng X , Wang F , Wells G
Ref : Prog Brain Res , 109 :125 , 1996
PubMedID: 9009699

Title : An automated method for acetylcholinesterase kinetics -
Author(s) : Anand R , Gore MG , Kerkut GA
Ref : Analytical Biochemistry , 70 :463 , 1976
PubMedID: 1267140